SUZ Stock Analysis: Suzano Papel e Celulose | NYSE
Paper & Paper Products | NYSE, USA | Market Cap: 10.382m USD | 12M Return: -4.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 19.5M
Qual. Beats: 0
Rev. Trend: 61.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Suzano S.A. is a Brazilian integrated producer of pulp and paper products serving both domestic and international markets, operating through two segments: Cellulose and Paper. Its product portfolio includes coated and uncoated printing and writing papers, paperboards, tissue papers, and market and fluff pulps, alongside a range of diversification activities spanning biofuel research, port terminal operations, power generation, lignin development, cellulose-based fibers and textile filaments, and forestry restoration. Founded in 1924 and headquartered in Salvador, Brazil, the company was renamed from Suzano Papel e Celulose S.A. to Suzano S.A. in April 2019, with its NYSE-listed ADRs trading under the ticker SUZ since 1996.
The global pulp and paper industry is highly capital-intensive, and Suzanos vertical integration - spanning forestry assets, in-house power generation, port logistics, and downstream product development - is typical of large-scale producers seeking to control input costs and supply chain reliability. Its listing in the GICS Paper Products sub-industry reflects a core revenue orientation toward commodity and specialty cellulose and paperboard markets.
- Hardwood pulp prices rise on constrained global supply
- Brazilian Real depreciation lifts dollar-denominated export revenues
- Tissue paper acquisitions expand consumer products segment margins
| Net Income: 11.4b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.74 > 1.0 |
| NWC/Revenue: 60.76% < 20% (prev 43.01%; Δ 17.75% < -1%) |
| CFO/TA 0.10 > 3% & CFO 16.7b > Net Income 11.4b |
| Net Debt (81.9b) to EBITDA (35.9b): 2.28 < 3 |
| Current Ratio: 3.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.24b) vs 12m ago 0.02% < -2% |
| Gross Margin: 31.10% > 18% (prev 40.54%; Δ -9.44% > 0.5%) |
| Asset Turnover: 30.98% > 50% (prev 31.88%; Δ -0.91% > 0%) |
| Interest Coverage Ratio: 3.73 > 6 (EBIT TTM 24.4b / Interest Expense TTM 6.54b) |
| A: 0.18 (Total Current Assets 42.2b - Total Current Liabilities 12.0b) / Total Assets 166b |
| B: 0.03 (Retained Earnings 4.33b / Total Assets 166b) |
| C: 0.15 (EBIT TTM 24.4b / Avg Total Assets 161b) |
| D: 0.41 (Book Value of Equity 48.0b / Total Liabilities 118b) |
| Altman-Z'' = 2.73 = A |
| DSRI: 0.95 (Receivables 7.44b/7.77b, Revenue 49.7b/49.5b) |
| GMI: 1.30 (GM 40.54% / 31.10%) |
| AQI: 1.01 (AQ_t 0.33 / AQ_t-1 0.33) |
| SGI: 1.00 (Revenue 49.7b / 49.5b) |
| TATA: -0.03 (NI 11.4b - CFO 16.7b) / TA 166b) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of August 04, 2026, the stock is trading at USD 8.53 with a total of 3,361,282 shares traded. Over the past week, the price has changed by +3.77%, over one month by +6.89%, over three months by -0.23% and over the past year by -4.92%.
Current recommended Stop Loss: 8.20 (which is 3.9% or 1.7 ATR below the current price).
Suzano Papel e Celulose has received a consensus analysts rating of 4.60. Therefore, it is recommended to buy SUZ.
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.6 | 47.4% |
Market Cap BRL = 52.7b (10.4b USD * 5.0793 USD.BRL)
P/E Trailing = 4.5459
P/E Forward = 8.9366
P/S = 0.2096
P/B = 1.0749
Revenue TTM = 49.7b BRL
EBIT TTM = 24.4b BRL
EBITDA TTM = 35.9b BRL
Long Term Debt = 87.3b BRL (from longTermDebt, last quarter)
Short Term Debt = 4.33b BRL (from shortTermDebt, last quarter)
Debt = 104b BRL (from shortLongTermDebtTotal, last quarter) + Leases 6.76b
Net Debt = 81.9b BRL (calculated: Debt 104b - CCE 22.3b)
Enterprise Value = 135b BRL (52.7b + Debt 104b - CCE 22.3b)
Interest Coverage Ratio = 3.73 (Ebit TTM 24.4b / Interest Expense TTM 6.54b)
EV/FCF = 32.10x (Enterprise Value 135b / FCF TTM 4.19b)
FCF Yield = 3.11% (FCF TTM 4.19b / Enterprise Value 135b)
FCF Margin = 8.43% (FCF TTM 4.19b / Revenue TTM 49.7b)
Net Margin = 22.89% (Net Income TTM 11.4b / Revenue TTM 49.7b)
Gross Margin = 31.10% ((Revenue TTM 49.7b - Cost of Revenue TTM 34.3b) / Revenue TTM)
Gross Margin QoQ = 28.82% (prev 29.44%)
Tobins Q-Ratio = 0.81 (Enterprise Value 135b / Total Assets 166b)
Interest Expense / Debt = 6.27% (Interest Expense 6.54b / Debt 104b)
Taxrate = 32.32% (5.45b / 16.8b)
NOPAT = 16.5b (EBIT 24.4b * (1 - 32.32%))
Current Ratio = 3.51 (Total Current Assets 42.2b / Total Current Liabilities 12.0b)
Debt / Equity = 2.17 (Debt 104b / totalStockholderEquity, last quarter 48.0b)
Debt / EBITDA = 2.28 (Net Debt 81.9b / EBITDA 35.9b)
Debt / FCF = 19.53 (Net Debt 81.9b / FCF TTM 4.19b)
Total Stockholder Equity = 45.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.09% (Net Income 11.4b / Total Assets 166b)
RoE = 25.28% (Net Income TTM 11.4b / Total Stockholder Equity 45.0b)
RoCE = 18.42% (EBIT 24.4b / Capital Employed (Equity 45.0b + L.T.Debt 87.3b))
RoIC = 10.60% (NOPAT 16.5b / Invested Capital 156b)
WACC = 5.62% (E(52.7b)/V(157b) * Re(8.33%) + D(104b)/V(157b) * Rd(6.27%) * (1-Tc(0.32)))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.71 | Cagr: -1.65%
[DCF] Terminal Value 73.10% ; FCFF base≈5.17b ; Y1≈4.53b ; Y5≈3.66b
[DCF] Fair Price = N/A (negative equity: EV 58.8b - Net Debt 81.9b = -23.1b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.15 | # QB: 0
Revenue Correlation: 61.38 | Revenue CAGR: 8.41% | SUE: -0.10 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=1.54 | Chg30d=+47.13% | Revisions=+25% | GrowthEPS=-26.0% | GrowthRev=+7.5%
EPS next Year (2027-12-31): EPS=1.01 | Chg30d=-6.05% | Revisions=+25% | GrowthEPS=-34.4% | GrowthRev=+14.8%